Literature DB >> 12390559

Is average adherence to HIV antiretroviral therapy enough?

David R Bangsberg, Steven G Deeks.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12390559      PMCID： PMC1495121          DOI： 10.1046/j.1525-1497.2002.20812.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  25 in total

1.  Effect of adherence to newly initiated antiretroviral therapy on plasma viral load.

Authors:  R Gross; W B Bilker; H M Friedman; B L Strom
Journal:  AIDS       Date:  2001-11-09       Impact factor: 4.177

2.  CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy.

Authors:  Steven G Deeks; Rebecca Hoh; Robert M Grant; Terri Wrin; Jason D Barbour; Amy Narvaez; Denise Cesar; Ken Abe; Mary Beth Hanley; Nicholas S Hellmann; Christos J Petropoulos; Joseph M McCune; Marc K Hellerstein
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

3.  Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic.

Authors:  J McNabb; J W Ross; K Abriola; C Turley; C H Nightingale; D P Nicolau
Journal:  Clin Infect Dis       Date:  2001-07-30       Impact factor: 9.079

4.  Full adherence to HAART: is it really necessary?

Authors:  Francesca Cainelli; Sandro Vento
Journal:  Arch Intern Med       Date:  2002-04-22

5.  Patient compliance and drug failure in protease inhibitor monotherapy.

Authors:  G F Vanhove; J M Schapiro; M A Winters; T C Merigan; T F Blaschke
Journal:  JAMA       Date:  1996-12-25       Impact factor: 56.272

6.  Drug resistance in patients experiencing early virological failure under a triple combination including indinavir.

Authors:  O Gallego; C de Mendoza; M J Pérez-Elías; J M Guardiola; J Pedreira; D Dalmau; J Gónzalez; A Moreno; J R Arribas; A Rubio; I García-Arata; M Leal; P Domingo; V Soriano
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

7.  Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up.

Authors:  Robert S Hogg; Katherine Heath; David Bangsberg; Benita Yip; Natasha Press; Michael V O'Shaughnessy; Julio S G Montaner
Journal:  AIDS       Date:  2002-05-03       Impact factor: 4.177

8.  Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients.

Authors:  Patricia García de Olalla; Hernando Knobel; Alexia Carmona; Ana Guelar; José L López-Colomés; Joan A Caylà
Journal:  J Acquir Immune Defic Syndr       Date:  2002-05-01       Impact factor: 3.731

9.  Virologic rebound on HAART in the context of low treatment adherence is associated with a low prevalence of antiretroviral drug resistance.

Authors:  John Christopher Walsh; Anton Louis Pozniak; Mark Richard Nelson; Sundhiya Mandalia; Brian George Gazzard
Journal:  J Acquir Immune Defic Syndr       Date:  2002-07-01       Impact factor: 3.731

10.  A prospective study of predictors of adherence to combination antiretroviral medication.

Authors:  Carol E Golin; Honghu Liu; Ron D Hays; Loren G Miller; C Keith Beck; Jeanette Ickovics; Andrew H Kaplan; Neil S Wenger
Journal:  J Gen Intern Med       Date:  2002-10       Impact factor: 5.128
View more
  42 in total

1.  Race-based medical mistrust, medication beliefs and HIV treatment adherence: test of a mediation model in people living with HIV/AIDS.

Authors:  Seth C Kalichman; Lisa Eaton; Moira O Kalichman; Tama Grebler; Cynthia Merely; Brandi Welles
Journal:  J Behav Med       Date:  2016-07-09

2.  Food insecurity and antiretroviral adherence among HIV positive adults who drink alcohol.

Authors:  Seth C Kalichman; Tamar Grebler; Christina M Amaral; Megan McKerney; Denise White; Moira O Kalichman; Chauncey Cherry; Lisa Eaton
Journal:  J Behav Med       Date:  2014-10

3.  Medication adherence in people dually treated for HIV infection and mental health conditions: test of the medications beliefs framework.

Authors:  Seth C Kalichman; Jennifer Pellowski; Christopher Kegler; Chauncey Cherry; Moira O Kalichman
Journal:  J Behav Med       Date:  2015-04-03

Review 4.  Physician contributions to disparities in HIV/AIDS care: the role of provider perceptions regarding adherence.

Authors:  Valerie E Stone
Journal:  Curr HIV/AIDS Rep       Date:  2005-11       Impact factor: 5.071

5.  The price of adherence: qualitative findings from HIV positive individuals purchasing fixed-dose combination generic HIV antiretroviral therapy in Kampala, Uganda.

Authors:  J T Crane; A Kawuma; J H Oyugi; J T Byakika; A Moss; P Bourgois; D R Bangsberg
Journal:  AIDS Behav       Date:  2006-07

Review 6.  Adherence-resistance relationships to combination HIV antiretroviral therapy.

Authors:  David R Bangsberg; Deanna L Kroetz; Steven G Deeks
Journal:  Curr HIV/AIDS Rep       Date:  2007-05       Impact factor: 5.071

7.  Mobile Health Intervention to Reduce HIV Transmission: A Randomized Trial of Behaviorally Enhanced HIV Treatment as Prevention (B-TasP).

Authors:  Seth C Kalichman; Chauncey Cherry; Moira O Kalichman; Lisa A Eaton; James J Kohler; Catherine Montero; Raymond F Schinazi
Journal:  J Acquir Immune Defic Syndr       Date:  2018-05-01       Impact factor: 3.731

8.  The information-motivation-behavioral skills model of ART adherence in a Deep South HIV+ clinic sample.

Authors:  K Rivet Amico; William Barta; Deborah J Konkle-Parker; Jeffrey D Fisher; Deborah H Cornman; Paul A Shuper; William A Fisher
Journal:  AIDS Behav       Date:  2007-09-18

9.  Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among african american men with HIV.

Authors:  Laura M Bogart; Glenn Wagner; Frank H Galvan; Denedria Banks
Journal:  J Acquir Immune Defic Syndr       Date:  2010-04       Impact factor: 3.731

10.  Intentional non-adherence to medications among HIV positive alcohol drinkers: prospective study of interactive toxicity beliefs.

Authors:  Seth C Kalichman; Tamar Grebler; Christina M Amaral; Megan McNerey; Denise White; Moira O Kalichman; Chauncey Cherry; Lisa Eaton
Journal:  J Gen Intern Med       Date:  2012-10-12       Impact factor: 5.128
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.